Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 94 | 2024 | 4838 | 7.230 |
Why?
|
CA-125 Antigen | 20 | 2024 | 286 | 4.870 |
Why?
|
Neoplasms, Glandular and Epithelial | 18 | 2017 | 484 | 2.480 |
Why?
|
Mucin-1 | 7 | 2021 | 543 | 1.690 |
Why?
|
Talc | 4 | 2022 | 47 | 1.450 |
Why?
|
Membrane Proteins | 12 | 2022 | 7880 | 1.240 |
Why?
|
Carcinoma, Endometrioid | 5 | 2019 | 271 | 1.130 |
Why?
|
Cystadenocarcinoma, Serous | 8 | 2023 | 450 | 1.120 |
Why?
|
Postmenopause | 5 | 2023 | 2461 | 1.080 |
Why?
|
Menopause | 4 | 2023 | 1626 | 1.010 |
Why?
|
Case-Control Studies | 50 | 2023 | 21746 | 0.920 |
Why?
|
Parity | 7 | 2023 | 929 | 0.850 |
Why?
|
Adenocarcinoma, Mucinous | 4 | 2019 | 506 | 0.720 |
Why?
|
Mexican Americans | 1 | 2021 | 166 | 0.720 |
Why?
|
Pelvic Inflammatory Disease | 1 | 2019 | 94 | 0.680 |
Why?
|
Genitalia, Female | 2 | 2019 | 146 | 0.680 |
Why?
|
Leukocytes, Mononuclear | 3 | 2022 | 1836 | 0.640 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 3 | 2019 | 198 | 0.640 |
Why?
|
Therapeutic Irrigation | 1 | 2019 | 301 | 0.630 |
Why?
|
Polymorphism, Single Nucleotide | 22 | 2021 | 15519 | 0.620 |
Why?
|
Mucins | 2 | 2013 | 564 | 0.590 |
Why?
|
Contraception | 1 | 2018 | 359 | 0.490 |
Why?
|
Autoantibodies | 5 | 2018 | 2035 | 0.470 |
Why?
|
Female | 105 | 2024 | 380194 | 0.470 |
Why?
|
Antibodies, Neoplasm | 2 | 2017 | 286 | 0.460 |
Why?
|
Homocysteine | 1 | 2017 | 647 | 0.460 |
Why?
|
Mastitis | 1 | 2013 | 41 | 0.460 |
Why?
|
Cystadenoma, Serous | 1 | 2014 | 102 | 0.450 |
Why?
|
Genetic Predisposition to Disease | 18 | 2019 | 17446 | 0.440 |
Why?
|
Parturition | 1 | 2017 | 441 | 0.440 |
Why?
|
Middle Aged | 65 | 2023 | 213383 | 0.430 |
Why?
|
Estrogen Replacement Therapy | 4 | 2020 | 1203 | 0.400 |
Why?
|
Telomere | 2 | 2020 | 910 | 0.390 |
Why?
|
Telomerase | 2 | 2016 | 730 | 0.390 |
Why?
|
Risk Factors | 38 | 2023 | 72290 | 0.380 |
Why?
|
Puerperal Disorders | 1 | 2013 | 275 | 0.380 |
Why?
|
Antibodies | 2 | 2022 | 2460 | 0.370 |
Why?
|
Menstrual Cycle | 4 | 2017 | 551 | 0.360 |
Why?
|
Logistic Models | 15 | 2019 | 13408 | 0.360 |
Why?
|
Mumps | 1 | 2010 | 64 | 0.350 |
Why?
|
Lymphocytes | 2 | 2017 | 2617 | 0.350 |
Why?
|
Polycystic Ovary Syndrome | 3 | 2019 | 370 | 0.350 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2018 | 8428 | 0.340 |
Why?
|
C-Reactive Protein | 2 | 2021 | 3778 | 0.340 |
Why?
|
Endometriosis | 3 | 2022 | 839 | 0.330 |
Why?
|
Humans | 109 | 2024 | 744343 | 0.330 |
Why?
|
New England | 5 | 2021 | 1022 | 0.330 |
Why?
|
Antigen-Antibody Complex | 1 | 2010 | 517 | 0.330 |
Why?
|
Dysmenorrhea | 2 | 2021 | 86 | 0.330 |
Why?
|
Ovariectomy | 1 | 2011 | 661 | 0.330 |
Why?
|
Adenocarcinoma, Clear Cell | 3 | 2019 | 221 | 0.320 |
Why?
|
Breast Neoplasms | 8 | 2018 | 20822 | 0.310 |
Why?
|
New Hampshire | 3 | 2016 | 172 | 0.310 |
Why?
|
Genetic Loci | 4 | 2017 | 2575 | 0.290 |
Why?
|
Inflammation | 4 | 2021 | 10638 | 0.290 |
Why?
|
Age Factors | 8 | 2021 | 18370 | 0.280 |
Why?
|
Adult | 41 | 2021 | 214055 | 0.270 |
Why?
|
Ovulation | 1 | 2007 | 189 | 0.270 |
Why?
|
Flavonoids | 1 | 2009 | 443 | 0.270 |
Why?
|
Alleles | 5 | 2017 | 6933 | 0.260 |
Why?
|
Aged | 35 | 2021 | 163280 | 0.260 |
Why?
|
Early Detection of Cancer | 6 | 2019 | 3086 | 0.260 |
Why?
|
Neutrophils | 2 | 2017 | 3719 | 0.260 |
Why?
|
Hysterectomy | 1 | 2011 | 927 | 0.260 |
Why?
|
Risk | 11 | 2021 | 9687 | 0.250 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2948 | 0.240 |
Why?
|
Nutrition Surveys | 3 | 2021 | 1660 | 0.240 |
Why?
|
MicroRNAs | 2 | 2017 | 3752 | 0.230 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3255 | 0.230 |
Why?
|
Genotype | 13 | 2019 | 12951 | 0.220 |
Why?
|
Carcinoma | 2 | 2022 | 2375 | 0.220 |
Why?
|
Area Under Curve | 5 | 2017 | 1654 | 0.220 |
Why?
|
Odds Ratio | 8 | 2018 | 9849 | 0.220 |
Why?
|
Office Visits | 1 | 2007 | 598 | 0.210 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4851 | 0.210 |
Why?
|
Proportional Hazards Models | 10 | 2021 | 12354 | 0.210 |
Why?
|
Endometrial Neoplasms | 1 | 2011 | 1353 | 0.210 |
Why?
|
Progestins | 2 | 2021 | 306 | 0.200 |
Why?
|
Genome-Wide Association Study | 11 | 2021 | 12261 | 0.200 |
Why?
|
Gold | 2 | 2022 | 484 | 0.190 |
Why?
|
Decision Support Techniques | 1 | 2011 | 1956 | 0.190 |
Why?
|
Physical Examination | 1 | 2007 | 1237 | 0.190 |
Why?
|
Genetic Association Studies | 7 | 2019 | 2703 | 0.190 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2023 | 548 | 0.190 |
Why?
|
Powders | 1 | 2020 | 80 | 0.180 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2019 | 964 | 0.180 |
Why?
|
Prognosis | 12 | 2021 | 29063 | 0.180 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2021 | 162 | 0.180 |
Why?
|
Contraceptives, Oral, Hormonal | 2 | 2019 | 188 | 0.180 |
Why?
|
Monocytes | 2 | 2022 | 2596 | 0.180 |
Why?
|
Genitalia | 1 | 2020 | 112 | 0.180 |
Why?
|
Lymphocyte Count | 1 | 2022 | 793 | 0.170 |
Why?
|
Mendelian Randomization Analysis | 4 | 2019 | 967 | 0.170 |
Why?
|
Intrauterine Devices | 1 | 2021 | 122 | 0.170 |
Why?
|
Mastocytosis, Systemic | 1 | 2021 | 100 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2024 | 3870 | 0.170 |
Why?
|
Platelet Count | 1 | 2022 | 781 | 0.170 |
Why?
|
Gonadal Steroid Hormones | 1 | 2023 | 712 | 0.170 |
Why?
|
Recreation | 2 | 2016 | 115 | 0.170 |
Why?
|
Breast Feeding | 2 | 2020 | 1338 | 0.160 |
Why?
|
Glucuronosyltransferase | 1 | 2019 | 128 | 0.160 |
Why?
|
Thymidylate Synthase | 1 | 2018 | 75 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2022 | 316 | 0.160 |
Why?
|
Genital Neoplasms, Female | 1 | 2024 | 523 | 0.160 |
Why?
|
Perineum | 1 | 2019 | 211 | 0.160 |
Why?
|
Pelvis | 2 | 2019 | 730 | 0.160 |
Why?
|
Pelvic Neoplasms | 1 | 2020 | 254 | 0.160 |
Why?
|
A Kinase Anchor Proteins | 1 | 2018 | 51 | 0.160 |
Why?
|
RNA, Antisense | 1 | 2018 | 138 | 0.160 |
Why?
|
Oligomenorrhea | 1 | 2017 | 45 | 0.150 |
Why?
|
Young Adult | 11 | 2021 | 56430 | 0.150 |
Why?
|
Antigens, Neoplasm | 3 | 2018 | 1988 | 0.150 |
Why?
|
beta-Endorphin | 1 | 2017 | 53 | 0.150 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2018 | 199 | 0.150 |
Why?
|
Receptor, Melanocortin, Type 2 | 1 | 2016 | 9 | 0.150 |
Why?
|
Keratin-13 | 1 | 2016 | 11 | 0.140 |
Why?
|
Biotinidase | 1 | 2016 | 19 | 0.140 |
Why?
|
Analgesics | 2 | 2021 | 1040 | 0.140 |
Why?
|
Receptors, Calcitriol | 1 | 2019 | 350 | 0.140 |
Why?
|
Glycomics | 1 | 2017 | 121 | 0.140 |
Why?
|
Serum | 1 | 2017 | 214 | 0.140 |
Why?
|
Blood Cell Count | 1 | 2017 | 403 | 0.140 |
Why?
|
Metal Nanoparticles | 1 | 2020 | 405 | 0.140 |
Why?
|
Prostatic Neoplasms | 3 | 2016 | 11124 | 0.130 |
Why?
|
Estradiol | 1 | 2023 | 2020 | 0.130 |
Why?
|
Risk Assessment | 10 | 2023 | 23338 | 0.130 |
Why?
|
Abortion, Spontaneous | 1 | 2021 | 544 | 0.130 |
Why?
|
RNA Editing | 1 | 2016 | 148 | 0.130 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2016 | 367 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 253 | 0.130 |
Why?
|
Hyperthyroidism | 1 | 2017 | 295 | 0.130 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 314 | 0.130 |
Why?
|
Abortion, Induced | 1 | 2021 | 458 | 0.130 |
Why?
|
Premenopause | 1 | 2019 | 1033 | 0.130 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 745 | 0.120 |
Why?
|
Massachusetts | 3 | 2016 | 8663 | 0.120 |
Why?
|
Germ Cells | 1 | 2018 | 631 | 0.120 |
Why?
|
Microscopy, Fluorescence | 1 | 2022 | 2699 | 0.120 |
Why?
|
Epidemiologic Research Design | 1 | 2018 | 367 | 0.120 |
Why?
|
Menarche | 1 | 2017 | 516 | 0.120 |
Why?
|
Pregnancy | 7 | 2023 | 29144 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2022 | 1917 | 0.120 |
Why?
|
Social Adjustment | 1 | 1996 | 631 | 0.120 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 501 | 0.110 |
Why?
|
Electrochemical Techniques | 1 | 2013 | 98 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2133 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2016 | 326 | 0.110 |
Why?
|
Prospective Studies | 7 | 2021 | 53288 | 0.110 |
Why?
|
Testosterone | 1 | 2023 | 2420 | 0.110 |
Why?
|
Serotonin | 1 | 2017 | 1017 | 0.110 |
Why?
|
Hypothyroidism | 1 | 2017 | 658 | 0.110 |
Why?
|
Gene Amplification | 1 | 2017 | 1063 | 0.110 |
Why?
|
Meta-Analysis as Topic | 4 | 2017 | 1344 | 0.100 |
Why?
|
Aged, 80 and over | 9 | 2021 | 57776 | 0.100 |
Why?
|
Body Height | 1 | 2018 | 1577 | 0.100 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 545 | 0.100 |
Why?
|
Nurses | 1 | 2021 | 2461 | 0.100 |
Why?
|
Luminescent Measurements | 1 | 2013 | 405 | 0.100 |
Why?
|
Genetic Variation | 2 | 2016 | 6544 | 0.100 |
Why?
|
Alternative Splicing | 1 | 2016 | 1117 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2021 | 2282 | 0.100 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6773 | 0.100 |
Why?
|
Salpingectomy | 1 | 2011 | 53 | 0.100 |
Why?
|
Habits | 1 | 2011 | 139 | 0.100 |
Why?
|
Smoking | 2 | 2019 | 8987 | 0.100 |
Why?
|
Polysaccharides | 1 | 2017 | 1053 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6171 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2915 | 0.090 |
Why?
|
Neoplasms | 3 | 2019 | 21683 | 0.090 |
Why?
|
Lymph Nodes | 2 | 2019 | 3474 | 0.090 |
Why?
|
ROC Curve | 3 | 2017 | 3527 | 0.090 |
Why?
|
Gene Expression Profiling | 5 | 2018 | 9438 | 0.090 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11031 | 0.090 |
Why?
|
Health Surveys | 1 | 2021 | 4037 | 0.090 |
Why?
|
Epididymal Secretory Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
Reproductive History | 1 | 2011 | 209 | 0.090 |
Why?
|
Neoplastic Stem Cells | 1 | 2018 | 1376 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1905 | 0.090 |
Why?
|
Environment | 2 | 2019 | 1124 | 0.090 |
Why?
|
beta-Defensins | 1 | 2010 | 57 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2014 | 1588 | 0.090 |
Why?
|
Quantitative Trait Loci | 4 | 2018 | 2019 | 0.090 |
Why?
|
Exercise | 2 | 2016 | 5615 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2018 | 5256 | 0.090 |
Why?
|
Contraceptives, Oral | 2 | 2023 | 564 | 0.090 |
Why?
|
Apigenin | 1 | 2009 | 14 | 0.090 |
Why?
|
Cell Lineage | 1 | 2018 | 2504 | 0.090 |
Why?
|
Microscopy, Polarization | 2 | 2019 | 88 | 0.090 |
Why?
|
Flavones | 1 | 2009 | 66 | 0.090 |
Why?
|
Homozygote | 1 | 2014 | 1785 | 0.080 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2009 | 58 | 0.080 |
Why?
|
United States | 7 | 2021 | 69872 | 0.080 |
Why?
|
Actins | 1 | 2016 | 2121 | 0.080 |
Why?
|
Adolescent | 7 | 2021 | 85781 | 0.080 |
Why?
|
Cohort Studies | 7 | 2018 | 40561 | 0.080 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 188 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1692 | 0.080 |
Why?
|
Survival Rate | 5 | 2021 | 12788 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3589 | 0.070 |
Why?
|
Comorbidity | 3 | 2021 | 10388 | 0.070 |
Why?
|
Social Class | 1 | 2016 | 1999 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2942 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5952 | 0.070 |
Why?
|
Vitamin D | 2 | 2019 | 3223 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13102 | 0.070 |
Why?
|
DNA, Neoplasm | 1 | 2012 | 1758 | 0.070 |
Why?
|
Social Support | 1 | 1996 | 2118 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2023 | 6538 | 0.070 |
Why?
|
Blood Platelets | 1 | 2017 | 2508 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2849 | 0.070 |
Why?
|
Biological Specimen Banks | 1 | 2011 | 711 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3712 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2018 | 3966 | 0.060 |
Why?
|
Survival Analysis | 2 | 2017 | 10252 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12959 | 0.060 |
Why?
|
Age Distribution | 1 | 2011 | 2902 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4286 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2019 | 4234 | 0.060 |
Why?
|
Algorithms | 2 | 2022 | 13881 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2788 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.060 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2024 | 139 | 0.060 |
Why?
|
Mutation | 3 | 2017 | 29786 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1152 | 0.060 |
Why?
|
Proteins | 1 | 2018 | 6103 | 0.060 |
Why?
|
Boston | 2 | 2007 | 9313 | 0.050 |
Why?
|
Proteomics | 1 | 2016 | 3638 | 0.050 |
Why?
|
Estrogens | 2 | 2022 | 1566 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6895 | 0.050 |
Why?
|
Cyclin E | 1 | 2022 | 172 | 0.050 |
Why?
|
Mental Health | 1 | 1996 | 3019 | 0.050 |
Why?
|
Immune Tolerance | 1 | 2011 | 2258 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.050 |
Why?
|
Preoperative Care | 1 | 2010 | 2250 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2022 | 13033 | 0.050 |
Why?
|
Chronic Disease | 2 | 2018 | 9146 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 13989 | 0.050 |
Why?
|
Time Factors | 3 | 2017 | 40075 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2019 | 2309 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12245 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2007 | 2539 | 0.040 |
Why?
|
Europe | 2 | 2017 | 3339 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39050 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2016 | 1782 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 644 | 0.040 |
Why?
|
Women's Health | 2 | 2019 | 2034 | 0.040 |
Why?
|
Hydro-Lyases | 1 | 2018 | 94 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12720 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9239 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2022 | 749 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14722 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 809 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4328 | 0.040 |
Why?
|
Obesity | 2 | 2019 | 12745 | 0.040 |
Why?
|
Enkephalin, Methionine | 1 | 2017 | 26 | 0.040 |
Why?
|
Incidence | 2 | 2016 | 20947 | 0.040 |
Why?
|
Carbohydrate Sequence | 1 | 2017 | 414 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5686 | 0.040 |
Why?
|
Fucose | 1 | 2017 | 125 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2011 | 19905 | 0.040 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2017 | 177 | 0.040 |
Why?
|
Hypertension | 1 | 2017 | 8480 | 0.040 |
Why?
|
Telomere-Binding Proteins | 1 | 2017 | 116 | 0.030 |
Why?
|
Population Surveillance | 2 | 2017 | 2616 | 0.030 |
Why?
|
Geography | 1 | 2018 | 669 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 973 | 0.030 |
Why?
|
Uterus | 1 | 2019 | 711 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2017 | 411 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1534 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2017 | 648 | 0.030 |
Why?
|
Morphogenesis | 1 | 2018 | 752 | 0.030 |
Why?
|
Glycosylation | 1 | 2017 | 1126 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2016 | 1095 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 767 | 0.030 |
Why?
|
Child, Preschool | 2 | 2021 | 41006 | 0.030 |
Why?
|
Data Mining | 1 | 2018 | 537 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.030 |
Why?
|
Object Attachment | 1 | 1996 | 313 | 0.030 |
Why?
|
History, 20th Century | 1 | 2021 | 2740 | 0.030 |
Why?
|
Personality Inventory | 1 | 1996 | 1030 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 545 | 0.030 |
Why?
|
Australia | 1 | 1996 | 1170 | 0.030 |
Why?
|
Male | 8 | 2018 | 350118 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9583 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 441 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 16689 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15076 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2017 | 794 | 0.030 |
Why?
|
Animals | 4 | 2016 | 168757 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1783 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 2008 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.020 |
Why?
|
Diet | 1 | 2009 | 7939 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2017 | 1149 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2636 | 0.020 |
Why?
|
Genetic Markers | 1 | 2016 | 2634 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1341 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3588 | 0.020 |
Why?
|
Epitopes | 1 | 2016 | 2571 | 0.020 |
Why?
|
Tacrolimus | 1 | 1993 | 743 | 0.020 |
Why?
|
Androgens | 1 | 2016 | 1281 | 0.020 |
Why?
|
Weight Gain | 1 | 2019 | 2292 | 0.020 |
Why?
|
Motor Activity | 1 | 2019 | 2714 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3494 | 0.020 |
Why?
|
Child | 2 | 2021 | 77709 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2183 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25043 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4740 | 0.020 |
Why?
|
Overweight | 1 | 2019 | 2371 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3617 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3920 | 0.020 |
Why?
|
Psychometrics | 1 | 1996 | 3002 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3558 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3521 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10481 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8089 | 0.020 |
Why?
|
Aspirin | 1 | 2017 | 3282 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1993 | 2382 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 2872 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6196 | 0.020 |
Why?
|
Signal Transduction | 2 | 2018 | 23403 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9727 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3703 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81183 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11366 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 2988 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12208 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6580 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1993 | 2119 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1993 | 3110 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5751 | 0.010 |
Why?
|
Mesocricetus | 1 | 1993 | 252 | 0.010 |
Why?
|
Splenectomy | 1 | 1993 | 395 | 0.010 |
Why?
|
Antilymphocyte Serum | 1 | 1993 | 492 | 0.010 |
Why?
|
Mycophenolic Acid | 1 | 1993 | 343 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1993 | 992 | 0.010 |
Why?
|
Cricetinae | 1 | 1993 | 2472 | 0.010 |
Why?
|
Drug Synergism | 1 | 1993 | 1792 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1993 | 2505 | 0.010 |
Why?
|
Biphenyl Compounds | 1 | 1993 | 913 | 0.010 |
Why?
|
Antibody Formation | 1 | 1993 | 1402 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1993 | 1537 | 0.000 |
Why?
|
Cyclophosphamide | 1 | 1993 | 2242 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1993 | 6489 | 0.000 |
Why?
|
Graft Survival | 1 | 1993 | 3737 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1993 | 4149 | 0.000 |
Why?
|
Graft Rejection | 1 | 1993 | 4397 | 0.000 |
Why?
|
Rats | 1 | 1993 | 24260 | 0.000 |
Why?
|